Cytosorbents Corp Share Price OTC Bulletin Board
Equities
US23283X2062
Advanced Medical Equipment & Technology
End-of-day quote
Other stock markets
|
||
- USD | - |
15/03 | Cytosorbents Corporation Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
14/03 | Earnings Flash (CTSO) CYTOSORBENTS Reports Q4 Revenue $8.7M, vs. Street Est of $9.8M | MT |
Sales 2024 * | 40.31M 3.37B | Sales 2025 * | 47.76M 3.99B | Capitalization | 43.77M 3.66B |
---|---|---|---|---|---|
Net income 2024 * | -20M -1.67B | Net income 2025 * | -9M -752M | EV / Sales 2024 * | 1.09 x |
Net cash position 2024 * | - 0 | Net cash position 2025 * | - 0 | EV / Sales 2025 * | 0.92 x |
P/E ratio 2024 * |
-2.24
x | P/E ratio 2025 * |
-3.96
x | Employees | - |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 90.62% |
Latest transcript on Cytosorbents Corp
Managers | Title | Age | Since |
---|---|---|---|
Phillip Chan
CEO | Chief Executive Officer | 53 | 24/08/24 |
Vincent Capponi
PSD | President | 66 | 25/02/25 |
Kathleen Bloch
DFI | Director of Finance/CFO | 69 | - |
Members of the board | Title | Age | Since |
---|---|---|---|
Michael Bator
CHM | Chairman | 60 | 14/15/14 |
Phillip Chan
CEO | Chief Executive Officer | 53 | 24/08/24 |
Edward Jones
BRD | Director/Board Member | 75 | 01/07/01 |
1st Jan change | Capi. | |
---|---|---|
+8.69% | 220B | |
+6.69% | 183B | |
+10.90% | 133B | |
+25.41% | 107B | |
+0.27% | 63.05B | |
+12.72% | 51.74B | |
+3.96% | 50.47B | |
+0.40% | 40.91B | |
+15.03% | 40.59B |